Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
OCGN Ocugen
1.290-0.040-3.01%
Close
02/03 16:00 ET
1.2900.0000.00%
Post Mkt Price 02/03 19:58 ET
High
1.350
Open
1.290
Turnover
6.51M
Low
1.270
Pre Close
1.330
Volume
4.98M
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
1 Reason to Buy Ocugen in 2023 and 2 Reasons to Sell
Ocugen Inc. Stock Falls Friday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Ocugen Inc. (OCGN) slid 3.01% to $1.29 Friday, on what proved to be an all-around poor trad
Ocugen Inc. Stock Rises Thursday, Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Ocugen Inc. (OCGN) rallied 4.72% to $1.33 Thursday, on what proved to be an all-around mixe
Ocugen Inc. Stock Remains Steady Wednesday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Ocugen Inc. (OCGN) were unchanged Wednesday, on what proved to be an all-around great tradi
Press Release: Ocugen Appoints Quan A. Vu as Chief Business Officer
Ocugen Appoints Quan A. Vu as Chief Business Officer MALVERN, Pa., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discoverin
Ocugen, Inc. to Present at 2023 BIO CEO & Investor Conference
MALVERN, Pa., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ:OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and
Ocugen Inc. Stock Falls Monday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Ocugen Inc. (OCGN) shed 4.72% to $1.21 Monday, on what proved to be an all-around dismal tr
Ocugen Inc. Stock Rises Friday, Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Ocugen Inc. (OCGN) rallied 5.83% to $1.27 Friday, on what proved to be an all-around positi
Why GeneDx Holdings Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket
Gainers Freightos Limited (NASDAQ:CRGO) shares rose 69.2% to $17.75 in pre-market trading. Freightos listed on the Nasdaq following merger with special purpose acquisition company, Gesher I Acquisiti
Ocugen Inc. Stock Remains Steady Wednesday, Still Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Ocugen Inc. (OCGN) were unchanged Wednesday, on what proved to be an all-around mixed tradi
Company Overview
More
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
CEO： Dr. Shankar Musunuri, M.B.A.,PhD
Market： NASDAQ
Listing Date： 12/03/2014
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet